Journal of Veterinary Science

  • 제24권3호
  • /
  • Pages.36.1-36.7
  • /
  • 2023
  • /
  • 1229-845X(pISSN)
  • /
  • 1976-555X(eISSN)
대한수의학회 (The Korean Society of Veterinary Science)
권호 표지
DOI QR코드

DOI QR Code

Lymphopenia predicts reduced survival in canine hepatocellular carcinoma

  • Jose Israel Suarez-Rodriguez (Department of Veterinary Clinical Sciences, Louisiana State University School of Veterinary Medicine) ;
  • Chin-Chi Liu (Department of Veterinary Clinical Sciences, Louisiana State University School of Veterinary Medicine) ;
  • Shannon Dehghanpir (Department of Veterinary Clinical Sciences, Louisiana State University School of Veterinary Medicine) ;
  • Andrea N. Johnston (Department of Veterinary Clinical Sciences, Louisiana State University School of Veterinary Medicine)
  • 투고 : 2022.10.23
  • 심사 : 2023.03.12
  • 발행 : 2023.05.31
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Platelet to lymphocyte ratio (PLR) is a prognostic marker in human hepatocellular carcinoma (HCC) however, its utility in canine HCC has not been explored. The aim of the study was to determine if PLR could predict survival outcomes in 42 dogs with HCC. PLR was not a significant predictive factor (p = 0.15) but lymphopenia alone was significantly correlated with a reduced probability of survival (p = 0.024). Further studies are needed to evaluate if peripheral lymphocyte count mirrors that of the tumor microenvironment in canine HCC.

키워드

과제정보

We would like to acknowledge the families and primary veterinarians of the dogs included in the study for providing patient information. We would also like to thank Medical Record Office personnel for assisting with the recovery of non-electronic medical records. Finally, thank you to Priscilla Devora for assistance identifying patients from the database of the Louisiana Animal Disease Diagnostic Laboratory.

참고문헌

  1. Patnaik AK, Hurvitz AI, Lieberman PH. Canine hepatic neoplasms: a clinicopathologic study. Vet Pathol. 1980;17(5):553-564. https://doi.org/10.1177/030098588001700504
  2. Moyer J, Lopez DJ, Balkman CE, Sumner JP. Factors associated with survival in dogs with a histopathological diagnosis of hepatocellular carcinoma: 94 cases (2007-2018). Open Vet J. 2021;11(1):144-153. https://doi.org/10.4314/ovj.v11i1.21
  3. Liptak JM, Dernell WS, Monnet E, Powers BE, Bachand AM, Kenney JG, et al. Massive hepatocellular carcinoma in dogs: 48 cases (1992-2002). J Am Vet Med Assoc. 2004;225(8):1225-1230. https://doi.org/10.2460/javma.2004.225.1225
  4. Vatnikov Y, Vilkovysky I, Kulikov E, Popova I, Khairova N, Gazin A, et al. Size of canine hepatocellular carcinoma as an adverse prognostic factor for surgery. J Adv Vet Anim Res. 2020;7(1):127-132. https://doi.org/10.5455/javar.2020.g401
  5. Pinero F, Dirchwolf M, Pessoa MG. Biomarkers in hepatocellular carcinoma: diagnosis, prognosis and treatment response assessment. Cells. 2020;9(6):1370.
  6. Singh G, Yoshida EM, Rathi S, Marquez V, Kim P, Erb SR, et al. Biomarkers for hepatocellular cancer. World J Hepatol. 2020;12(9):558-573. https://doi.org/10.4254/wjh.v12.i9.558
  7. Templeton AJ, Ace O, McNamara MG, Al-Mubarak M, Vera-Badillo FE, Hermanns T, et al. Prognostic role of platelet to lymphocyte ratio in solid tumors: a systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev. 2014;23(7):1204-1212. https://doi.org/10.1158/1055-9965.EPI-14-0146
  8. Ma W, Zhang P, Qi J, Gu L, Zang M, Yao H, et al. Prognostic value of platelet to lymphocyte ratio in hepatocellular carcinoma: a meta-analysis. Sci Rep. 2016;6(1):35378.
  9. Kinsey JR, Gilson SD, Hauptman J, Mehler SJ, May LR. Factors associated with long-term survival in dogs undergoing liver lobectomy as treatment for liver tumors. Can Vet J. 2015;56(6):598-604.
  10. Wada Y, Nakashima O, Kutami R, Yamamoto O, Kojiro M. Clinicopathological study on hepatocellular carcinoma with lymphocytic infiltration. Hepatology. 1998;27(2):407-414. https://doi.org/10.1002/hep.510270214
  11. Shirabe K, Motomura T, Muto J, Toshima T, Matono R, Mano Y, et al. Tumor-infiltrating lymphocytes and hepatocellular carcinoma: pathology and clinical management. Int J Clin Oncol. 2010;15(6):552-558. https://doi.org/10.1007/s10147-010-0131-0
  12. Hiraoka N. Tumor-infiltrating lymphocytes and hepatocellular carcinoma: molecular biology. Int J Clin Oncol. 2010;15(6):544-551. https://doi.org/10.1007/s10147-010-0130-1
  13. Chang KM. Regulatory T cells and the liver: a new piece of the puzzle. Hepatology. 2005;41(4):700-702. https://doi.org/10.1002/hep.20678